XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.24.3

Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Accounting Policies [Abstract] |
Summary of Impact of Accounts Receivable Reserves on Gross Trade Accounts Receivable Balances | The following table summarizes the impact of accounts receivable reserves on the gross trade accounts receivable balances as of September 30, 2024 and December 31, 2023:
In thousands |  | September 30, 2024 |  |  | December 31, 2023 |
Gross trade accounts receivable |  | $ | 130,254 |  |  | $ | 160,686 |
Trade allowances |  |  | (12,517 | ) |  |  | (18,834 | )
Chargebacks |  |  | (5,095 | ) |  |  | (8,289 | )
Accounts receivable, net |  | $ | 112,642 |  |  | $ | 133,563 |
Calculation of Net Loss and Number of Shares Used to Compute Basic and Diluted Net Loss per Share | The calculation of net loss and the number of shares used to compute basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:
|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
In thousands |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Net loss—basic and diluted |  | $ | (25,134 | ) |  | $ | (19,311 | ) |  | $ | (33,565 | ) |  | $ | (53,331 | )
Weighted average shares outstanding—basic and diluted |  |  | 411,150 |  |  |  | 408,417 |  |  |  | 410,786 |  |  |  | 407,489 |
Loss per share—basic and diluted (1) |  | $ | (0.06 | ) |  | $ | (0.05 | ) |  | $ | (0.08 | ) |  | $ | (0.13 | )
(1) Excluding the licensing revenue change in estimates and Medicaid change in estimate, both discussed in Note 7 – Revenue Recognition, net loss per share, basic and diluted, for the three months ended September 30, 2023 would have been $(0.06) and net loss per share for the nine months ended September 30, 2024 and 2023 would have been $(0.09) and $(0.19), respectively.
Anti-Dilutive Securities Not Included in the Computation of Net Loss per Share | For the three and nine months ended September 30, 2024 and 2023, the following potentially dilutive securities were not included in the computation of net loss per share because the effect would be anti-dilutive or because performance criteria were not yet met for awards contingent upon such measures:
|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
In thousands |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Stock options |  |  | 29,071 |  |  |  | 27,797 |  |  |  | 29,071 |  |  |  | 27,797 |
Restricted stock and restricted stock units |  |  | 14,696 |  |  |  | 13,676 |  |  |  | 14,696 |  |  |  | 13,676 |
Estimated Fair Value of Assets and Liability | The following tables present information about the estimated fair value of the Company’s assets and liabilities as of September 30, 2024 and December 31, 2023, and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:
|  | September 30, 2024 |
In thousands |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Asset: |  |  |  |  |  |  |  |  |  |  |  |
Money Market Fund |  | $ | 73,927 |  |  | $ | 73,927 |  |  | $ | — |  |  | $ | — |
U.S. Treasury Securities |  |  | 165,720 |  |  |  | 165,720 |  |  |  | — |  |  |  | — |
Repo Securities |  |  | 5,000 |  |  |  | — |  |  |  | 5,000 |  |  |  | — |
Total |  | $ | 244,647 |  |  | $ | 239,647 |  |  | $ | 5,000 |  |  | $ | — |
|  | December 31, 2023 |
In thousands |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Asset: |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury Securities |  | $ | 123,992 |  |  | $ | 123,992 |  |  | $ | — |  |  | $ | — |
Money Market Fund |  |  | 99,226 |  |  |  | 99,226 |  |  |  | — |  |  |  | — |
Agency Securities |  |  | 8,912 |  |  |  | — |  |  |  | 8,912 |  |  |  | — |
Repo Securities |  |  | 3,250 |  |  |  | — |  |  |  | 3,250 |  |  |  | — |
Total |  | $ | 235,380 |  |  | $ | 223,218 |  |  | $ | 12,162 |  |  | $ | — |
Summary of Restructuring Charges | The following table sets forth the components of the Company's restructuring charges for the three and nine months ended September 30, 2023 (none in 2024):
|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
In thousands |  | 2023 |  |  | 2023 |
Restructuring expense |  | $ | — |  |  | $ | 10,154 |
Vendor contract charges |  |  | 711 |  |  |  | 589 |
Total restructuring expense |  |  | 711 |  |  |  | 10,743 |
Restructuring inventory |  |  | 12,674 |  |  |  | 39,228 |
Stock forfeitures |  |  | 1,034 |  |  |  | 1,034 |
Total restructuring costs incurred |  | $ | 14,419 |  |  | $ | 51,005 |
Change in Restructuring Liability | The following table shows the change in restructuring liability, which is included within accrued expenses and other current liabilities:
In thousands |  | Restructuring Liability |
Balance at December 31, 2023 |  | $ | 13,589 |
Costs incurred |  |  | — |
Payments |  |  | (3,687 | )
Balance at September 30, 2024 |  | $ | 9,902 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration